Financing Diagnostics in the Post-COVID World

Financing Diagnostics in the Post-COVID World

Published in MedTech Strategist

Authors: Craig Steger, Oded Ben-Joseph, PhD, Carey Gallant, Outcome Capital, and Wendy Diller

Abstract:
During the COVID-19 pandemic, the US government imposed sweeping pandemic measures on the nation allowing millions of Americans to receive free tests, vaccines, and treatments aimed to prevent spread of a potentially life-threatening, highly contagious disease. These COVID-19 emergency declarations will end on May 11, marking a close to the US response to the global pandemic. With the end of the pandemic, the in vitro diagnostics (IVD) industry is confronting a reckoning-one that was predicable but is still painful.